Cargando…

Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system

BACKGROUND: The probiotic Saccharomyces boulardii CNCM I-745 (also known as Saccharomyces cerevisiae HANSEN CBS 5926; in the following S. boulardii) has proven its effectiveness in preventive and therapeutic treatment of many gastrointestinal diseases, especially diseases associated with acute diarr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stier, Heike, Bischoff, Stephan C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027949/ https://www.ncbi.nlm.nih.gov/pubmed/27695355 http://dx.doi.org/10.2147/CEG.S111003

Ejemplares similares

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections
por: Czerucka, Dorota, et al.
Publicado: (2019)

Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota
por: Spatz, Madeleine, et al.
Publicado: (2023)

Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS
por: Brun, Paola, et al.
Publicado: (2017)

Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review
por: Gopalan, Sarath, et al.
Publicado: (2023)

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption
por: Terciolo, Chloe, et al.
Publicado: (2019)

The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children
por: Bin, Zhang, et al.
Publicado: (2015)

Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS
por: Brun, Paola, et al.
Publicado: (2017)

Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review
por: Moré, Margret I, et al.
Publicado: (2018)

The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT Toxin
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2015)

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review
por: Moré, Margret I, et al.
Publicado: (2015)

Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers
por: Kabbani, Toufic A., et al.
Publicado: (2016)

Saccharomyces boulardii CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers
por: Kelly, Ciaran Patrick, et al.
Publicado: (2019)

Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases
por: Kaźmierczak-Siedlecka, Karolina, et al.
Publicado: (2020)

Saccharomyces boulardii Strain CNCM I-745 Modifies the Mononuclear Phagocytes Response in the Small Intestine of Mice Following Salmonella Typhimurium Infection
por: Ibáñez, Lidia, et al.
Publicado: (2019)

Retrospective analysis of EMR database to assess the effectiveness of Saccharomyces boulardii CNCM I-745 in children with acute diarrhoea during routine clinical practice
por: Ragavan, P.S.K., et al.
Publicado: (2020)

Inhibition of In Vitro Clostridioides difficile Biofilm Formation by the Probiotic Yeast Saccharomyces boulardii CNCM I-745 through Modification of the Extracellular Matrix Composition
por: Lacotte, Pierre-Alexandre, et al.
Publicado: (2022)

Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis
por: Madel, Maria-Bernadette, et al.
Publicado: (2023)

Effect of Chilled Storage on Antioxidant Capacities and Volatile Flavors of Synbiotic Yogurt Made with Probiotic Yeast Saccharomyces boulardii CNCM I-745 in Combination with Inulin
por: Sarwar, Abid, et al.
Publicado: (2022)

Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis
por: Altcheh, Jaime, et al.
Publicado: (2022)

Effects of Probiotic Fermented Fruit Juice-Based Biotransformation by Lactic Acid Bacteria and Saccharomyces boulardii CNCM I-745 on Anti-Salmonella and Antioxidative Properties
por: Laosee, Wanida, et al.
Publicado: (2022)

Effectiveness of Saccharomyces Boulardii CNCM I-745 probiotic in acute inflammatory viral diarrhoea in adults: results from a single-centre randomized trial
por: Salazar-Parra, Marcela AG, et al.
Publicado: (2023)

UPLC-Q-TOF-MS based metabolomics and chemometric analyses for green tea fermented with Saccharomyces boulardii CNCM I-745 and Lactiplantibacillus plantarum 299V
por: Wang, Rui, et al.
Publicado: (2022)

Influence of Three Probiotics Strains, Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. Lactis BB-12 and Saccharomyces boulardii CNCM I-745 on the Biochemical and Haematological Profiles and Body Weight of Healthy Rabbits
por: Kadja, Louiza, et al.
Publicado: (2021)

Evaluation of nutritional and physicochemical characteristics of soy yogurt by Lactobacillus plantarum KU985432 and Saccharomyces boulardii CNCMI-745
por: Mehaya, Fathy M., et al.
Publicado: (2023)

Effect of Feeding Saccharomyces cerevisiae boulardii CNCM I-1079 to Sows and Piglets on Piglets’ Immune Response after Vaccination against Actinobacillus pleuropneumoniae
por: Bravo de Laguna, Fernando, et al.
Publicado: (2022)

Dietary Saccharomyces cerevisiae boulardii CNCM I-1079 Positively Affects Performance and Intestinal Ecosystem in Broilers during a Campylobacter jejuni Infection
por: Massacci, Francesca Romana, et al.
Publicado: (2019)

Effect of Saccharomyces boulardii CNCM-I 3799 and Bacillus subtilis CU-1 on Acute Watery Diarrhea: A Randomized Double-Blind Placebo-Controlled Study in Indian Children
por: Ghosh, Apurba, et al.
Publicado: (2021)

Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System
por: Hudson, Lauren E., et al.
Publicado: (2016)

Saccharomyces Cerevisiae Var Boulardii CNCM I–1079 Reduces Expression of Genes Involved in Inflammatory Response in Porcine Cells Challenged by Enterotoxigenic E. Coli and Influences Bacterial Communities in an In Vitro Model of the Weaning Piglet Colon
por: Gresse, Raphaële, et al.
Publicado: (2021)

Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
por: Sulik-Tyszka, Beata, et al.
Publicado: (2017)

Biocontainment strategies for in vivo applications of Saccharomyces boulardii
por: Hedin, Karl Alex, et al.
Publicado: (2023)

Effect of Saccharomyces boulardii and Bacillus subtilis B10 on gut microbiota modulation in broilers
por: Qin, Chubin, et al.
Publicado: (2018)

Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?
por: Pais, Pedro, et al.
Publicado: (2020)

Safety and efficacy of a feed additive consisting of Bacillus subtilis strains CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 for all animal species (Nolivade)
por: Bampidis, Vasileios, et al.
Publicado: (2021)

Efficacy of a feed additive consisting of Bacillus subtilis strains CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 for all animal species (MiXscience)
por: Bampidis, Vasileios, et al.
Publicado: (2023)

Effect of Saccharomyces boulardii and Mode of Delivery on the Early Development of the Gut Microbial Community in Preterm Infants
por: Zeber-Lubecka, Natalia, et al.
Publicado: (2016)

Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
por: Yu, Lei, et al.
Publicado: (2017)

Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on Hepatic Steatosis in Zucker Rats
por: Plaza-Diaz, Julio, et al.
Publicado: (2014)

Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis
por: Cayzeele-Decherf, Amélie, et al.
Publicado: (2017)

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
por: Roselletti, Elena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cnkgirmobpg32oosun55ighi6j